Literature review on point-of-care testing (August 2009-December 2010)

Point of Care

Volumn 10, Issue 2, 2011, Pages 63-68

  Melanson, Stacy E F ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

acute coronary syndrome; Chlamydia; chronic kidney disease; coagulation; congestive heart failure; creatinine; D dimer; diabetes; glucose; hemoglobin A1c; HIV; infectious disease; influenza; INR; NT proBNP; platelet aggregation; point of care testing; toxicology; troponin

Indexed keywords

EID: 79958847950     PISSN: 1533029X     EISSN: 15330303     Source Type: Journal    
DOI: 10.1097/POC.0b013e31821bd6e0     Document Type: Review

References (81)

1. Clinics in Laboratory Medicine. Philadelphia, PA: WB Saunders Company; 2009.
2. Blattner K, Nixon G, Dovey S, et al. Changes in clinical practice and patient disposition following the introduction of point-of-care testing in a rural hospital. Health Policy. 2010;96(1):7-12.
3. Blattner K, Nixon G, Jaye C, et al. Introducing point-of-care testing into a rural hospital setting: thematic analysis of interviews with providers. J Prim Health Care. 2010;2(1):54-60.
4. Casagranda I. Point-of-care testing in critical care: the clinician's point of view. Clin Chem Lab Med. 2010;48(7):931-934.
5. Di Serio F, Petronelli MA, Sammartino E. Laboratory testing during critical care transport: point-of-care testing in air ambulances. Clin Chem Lab Med. 2010;48(7):955-961.
6. Gialamas A, St John A, Laurence CO, et al. Point-of-care testing for patients with diabetes, hyperlipidaemia or coagulation disorders in the general practice setting: a systematic review. Fam Pract. 2010;27(1):17-24.
7. Gialamas A, Yelland LN, Ryan P, et al. Does point-of-care testing lead to the same or better adherence to medication? A randomised controlled trial: the PoCT in General Practice Trial. Med J Aust. 2009;191(9):487-491.
8. Laurence CO, Gialamas A, Bubner T, et al. Patient satisfaction with point-of-care testing in general practice. Br J Gen Pract. 2010;60(572):e98- e104.
9. Laurence CO, Moss JR, Briggs NE, et al. The cost-effectiveness of point of care testing in a general practice setting: results from a randomised controlled trial. BMC Health Serv Res. 2010;10:165.
10. Lee-Lewandrowski E, Gregory K, Lewandrowski K. Point of care testing in a large urban academic medical center: evolving test menu and clinical applications. Clin Chim Acta. 2010;411(21-22):1799-1805.
11. Lippi G, Plebani M, Favaloro EJ, et al. Laboratory testing in pharmacies. Clin Chem Lab Med. 2010;48(7):943-953.
12. Snyder ML, Carter A, Jenkins K, et al. Patient misidentifications caused by errors in standard bar code technology. Clin Chem. 2010;56(10):1554-1560.
13. Van Cott EM. Point-of-care testing in coagulation. Clin Lab Med. 2009;29(3):543-553.
14. Perry DJ, Fitzmaurice DA, Kitchen S, et al. Point-of-care testing in haemostasis. Br J Haematol. 2010;150(5):501-514.
15. Rizos T, Herweh C, Jenetzky E, et al. Point-of-care international normalized ratio testing accelerates thrombolysis in patients with acute ischemic stroke using oral anticoagulants. Stroke. 2009;40(11):3547-3551.
16. Ryan F, O'Shea S, Byrne S. The reliability of point-of-care prothrombin time testing. A comparison of CoaguChek S and XS INR measurements with hospital laboratory monitoring. Int J Lab Hematol. 2010;32(1 Pt 1):e26-e33.
17. Tripodi A, Chantarangkul V, Primignani M, et al. Point-of-care coagulation monitors calibrated for the international normalized ratio for cirrhosis (INRliver) can help to implement the INRliver for the calculation of the MELD score. J Hepatol. 2009;51(2):288-295.
18. Urwyler N, Staub LP, Beran D, et al. Is perioperative point-of-care prothrombin time testing accurate compared to the standard laboratory test? Thromb Haemost. 2009;102(4):779-786.
19. Yelland LN, Gialamas A, Laurence CO, et al. Assessing agreement between point of care and pathology laboratory results for INR: experiences from the Point of Care Testing in General Practice Trial. Pathology. 2010;42(2):155-159.
20. Urwyler N, Trelle S, Theiler L, et al. Does point of care prothrombin time measurement reduce the transfusion of fresh frozen plasma in patients undergoing major surgery? The POC-OP randomized-controlled trial. Trials. 2009;10:107.
21. Matchar DB, Jacobson A, Dolor R, et al. Effect of home testing of international normalized ratio on clinical events. N Engl J Med. 2010;363(17):1608-1620.
22. Garcia-Alamino JM, Ward AM, Alonso-Coello P, et al. Self-monitoring and self-management of oral anticoagulation. Cochrane Database Syst Rev. 2010;(4):CD003839.
23. Geersing GJ, Toll DB, Janssen KJ, et al. Diagnostic accuracy and user-friendliness of 5 point-of-care D-dimer tests for the exclusion of deep vein thrombosis. Clin Chem. 2010;56(11):1758-1766.
24. Lee-Lewandrowski E, Nichols J, Van Cott E, et al. Implementation of a rapid whole blood D-dimer test in the emergency department of an urban academic medical center: impact on ED length of stay and ancillary test utilization. Am J Clin Pathol. 2009;132(3):326-331.
25. Bidet A, Jais C, Puymirat E, et al. VerifyNow and VASP phosphorylation assays give similar results for patients receiving clopidogrel, but they do not always correlate with platelet aggregation. Platelets. 2010;21(2):94-100.
26. Mangiacapra F, Patti G, Peace A, et al. Comparison of platelet reactivity and periprocedural outcomes in patients with versus without diabetes mellitus and treated with clopidogrel and percutaneous coronary intervention. Am J Cardiol. 2010;106(5):619-623.
27. Pinto Slottow TL, Bonello L, Gavini R, et al. Prevalence of aspirin and clopidogrel resistance among patients with and without drug-eluting stent thrombosis. Am J Cardiol. 2009;104(4):525-530.
28. Schuhmann CG, Sohn HY, Nagel J, et al. Clinical management of clopidogrel inefficiency by point of care platelet function testing and individual adjustment of anti-platelet therapy - initial experiences. Platelets. 2009;20(7):498-504.
29. Azam SM, Jozic J. Variable platelet responsiveness to aspirin and clopidogrel: role of platelet function and genetic polymorphism testing. Transl Res. 2009;154(6):309-313.
30. Sobieraj-Teague M, Eikelboom JW. Point-of-care testing for assessment of adequacy of oral antiplatelet therapy in patients with cardiovascular disease. Future Cardiol. 2010;6(3):289-299.
31. Williams CD, Cherala G, Serebruany V. Application of platelet function testing to the bedside. Thromb Haemost. 2010;103(1):29-33.
32. Clerc O, Greub G. Routine use of point-of-care tests: usefulness and application in clinical microbiology. Clin Microbiol Infect. 2010;16(8):1054-1061.
33. Dale SE. The role of rapid antigen testing for influenza in the era of molecular diagnostics. Mol Diagn Ther. 2010;14(4):205-214.
34. Fernandez C, Cataletto M, Lee P, et al. Rapid influenza A testing for novel H1N1: point-of-care performance. Postgrad Med. 2010;122(1):28-33.
35. Ganzenmueller T, Kluba J, Hilfrich B, et al. Comparison of the performance of direct fluorescent antibody staining, a point-of-care rapid antigen test and virus isolation with that of RT-PCR for the detection of novel 2009 influenza A (H1N1) virus in respiratory specimens. J Med Microbiol. 2010;59(Pt 6):713-717.
36. Hislop J, Quayyum Z, Flett G, et al. Systematic review of the clinical effectiveness and cost-effectiveness of rapid point-of-care tests for the detection of genital chlamydia infection in women and men. Health Technol Assess. 2010;14(29):1-97, iii-iv.
37. Mishra S, Naik B, Venugopal B, Kudur P, et al. Syphilis screening among female sex workers in Bangalore, India: comparison of point-of-care testing and traditional serological approaches. Sex Transm Infect. 2010;86(3):193-198.
38. Reed JL, Simendinger L, Griffeth S, et al. Point-of-care testing for sexually transmitted infections increases awareness and short-term abstinence in adolescent women. J Adolesc Health. 2010;46(3):270-277.
39. van Dommelen L, van Tiel FH, Ouburg S, et al. Alarmingly poor performance in Chlamydia trachomatis point-of-care testing. Sex Transm Infect. 2010;86(5):355-359.
40. Campbell S, Fedoriw Y. HIV testing near the patient: changing the face of HIV testing. Clin Lab Med. 2009;29(3):491-501.
41. Lochhead MJ. Insights from the 2010 HIV Diagnostics Conference. Expert Rev Mol Diagn. 2010;10(5):565-567.
42. Pandori MW, Branson BM. 2010 HIV Diagnostics Conference. Expert Rev Anti Infect Ther. 2010;8(6):631-633.
43. Lee HH, Dineva MA, Chua YL, et al. Simple amplification-based assay: a nucleic acid-based point-of-care platform for HIV-1 testing. J Infect Dis. 2010;201(Suppl 1):S65-S72.
44. Mtapuri-Zinyowera S, Chideme M, Mangwanya D, et al. Evaluation of the PIMA point-of-care CD4 analyzer in VCT clinics in Zimbabwe. J Acquir Immune Defic Syndr. 2010;55(1):1-7.
45. Siegel M, Kennedy L, Rexroth K, et al. Better but not ideal acceptance of routine inpatient HIV point-of-care testing among veterans in a high prevalence area. J Acquir Immune Defic Syndr. 2010;55(2):205-210.
46. Shrestha RK, Begley EB, Hutchinson AB, et al. Costs and effectiveness of partner counseling and referral services with rapid testing for HIV in Colorado and Louisiana, United States. Sex Transm Dis. 2009;36(10):637-641.
47. Yao K, Wafula W, Bile EC, et al. Ensuring the quality of HIV rapid testing in resource-poor countries using a systematic approach to training. Am J Clin Pathol. 2010;134(4):568-572.
48. Davies J, van Oosterhout JJ, Nyirenda M, et al. Reliability of rapid testing for hepatitis B in a region of high HIV endemicity. Trans R Soc Trop Med Hyg. 2010;104(2):162-164.
49. Lee SR, Yearwood GD, Guillon GB, et al. Evaluation of a rapid, point-of-care test device for the diagnosis of hepatitis C infection. J Clin Virol. 2010;48(1):15-17.
50. Alter D, Deines G. Tight glycemic control and point-of-care testing. Clin Lab Med. 2009;29(3):511-522.
51. Rice MJ, Pitkin AD, Coursin DB. Review article: glucose measurement in the operating room: more complicated than it seems. Anesth Analg. 2010;110(4):1056-1065.
52. Branco RG, Chavan A, Tasker RC. Pilot evaluation of continuous subcutaneous glucose monitoring in children with multiple organ dysfunction syndrome. Pediatr Crit Care Med. 2010;11(3):415-419.
53. Torjman MC, Goldberg ME, Littman JJ, et al. Pilot evaluation of a prototype critical care blood glucose monitor in normal volunteers. J Diabetes Sci Technol. 2009;3(6):1233-1241.
54. Vanavanan S, Santanirand P, Chaichanajarernkul U, et al. Performance of a new interference-resistant glucose meter. Clin Biochem. 2010;43(1-2):186-192.
55. Wahl HG. How accurately do we measure blood glucose levels in intensive care unit (ICU) patients? Best Pract Res Clin Anaesthesiol. 2009;23(4):387-400.
56. A1c determination. Diabetes Metab. 2010;36(2):158-164.
57. Yeo CP, Tan CH, Jacob E. Haemoglobin A1c: evaluation of a new HbA1c point-of-care analyser Bio-Rad in2it in comparison with the DCA 2000 and central laboratory analysers. Ann Clin Biochem. 2009;46(Pt 5):373-376.
58. Schnabl KL, Bagherpoor S, Diker P, et al. Evaluation of the analytical performance of the Nova StatSensor creatinine meter and reagent strip technology for whole blood testing. Clin Biochem. 2010;43(12):1026-1029.
59. Shephard M, Peake M, Corso O, et al. Assessment of the Nova StatSensor whole blood point-of-care creatinine analyzer for the measurement of kidney function in screening for chronic kidney disease. Clin Chem Lab Med. 2010;48(8):1113-1119.
60. Lewandrowski K. Point-of-care testing for cardiac markers in acute coronary syndromes and heart failure. Clin Lab Med. 2009;29(3):561-571.
61. Takakuwa KM, Ou FS, Peterson ED, et al. The usage patterns of cardiac bedside markers employing point-of-care testing for troponin in nonYST-segment elevation acute coronary syndrome: results from CRUSADE. Clin Cardiol. 2009;32(9):498-505.
62. Zaninotto M, Mion MM, Di Serio F, et al. PATHFAST NT-proBNP (N-terminal-pro B type natriuretic peptide): a multicenter evaluation of a new point-of-care assay. Clin Chem Lab Med. 2010;48(7): 1029-1034.
63. Melanson SE. Drug-of-abuse testing at the point of care. Clin Lab Med. 2009;29(3):503-509.
64. Wu AH. Limitations of point-of-care testing in the ED or ICU: a role for regional centralized toxicology laboratories. Clin Pharmacol Ther. 2010;88(3):295-298.
65. Manchikanti L, Malla Y, Wargo BW, et al. Protocol for accuracy of point of care (POC) or in-office urine drug testing (immunoassay) in chronic pain patients: a prospective analysis of immunoassay and liquid chromatography tandem mass spectrometry (LC/MS/MS). Pain Physician. 2010;13(1):E1-E22.
66. Kaneko E, Yasuda H, Higurashi A, et al. Spot test of urinary protein using erythrosin B and a membrane film. Analyst. 2010;135(7):1564-1568.
67. Osei-Bimpong A, Jury C, McLean R, et al. Point-of-care method for total white cell count: an evaluation of the HemoCue WBC device. Int J Lab Hematol. 2009;31(6):657-664.
68. Van Hecke I, Vanden Bempt I, Malfait R, et al. Evaluation of the Sysmex pocH-1001 haematology analyser in an outdoor oncology service. Acta Clin Belg. 2010;65(4):248-251.
69. Oh SW, Kim YM, Kim HJ, et al. Point-of-care fluorescence immunoassay for prostate specific antigen. Clin Chim Acta. 2009;406(1-2):18-22.
70. Goyal M, Pines JM, Drumheller BC, et al. Point-of-care testing at triage decreases time to lactate level in septic patients. J Emerg Med. 2010;38(5):578-581.
71. Shapiro NI, Fisher C, Donnino M, et al. The feasibility and accuracy of point-of-care lactate measurement in emergency department patients with suspected infection. J Emerg Med. 2010;39(1):89-94.
72. Cals JW, Chappin FH, Hopstaken RM, et al. C-reactive protein point-of-care testing for lower respiratory tract infections: a qualitative evaluation of experiences by GPs. Fam Pract. 2010;27(2):212-218.
73. Cals JW, Schot MJ, de Jong SA, et al. Point-of-care C-reactive protein testing and antibiotic prescribing for respiratory tract infections: a randomized controlled trial. Ann Fam Med. 2010;8(2):124-133.
74. Jakobsen KA, Melbye H, Kelly MJ, et al. Influence of CRP testing and clinical findings on antibiotic prescribing in adults presenting with acute cough in primary care. Scand J Prim Health Care. 2010;28(4):229-236.
75. Balagopal SK, Sainu A, Thomas V. Evaluation of leucocyte esterase reagent strip test for the rapid bedside diagnosis of spontaneous bacterial peritonitis. Indian J Gastroenterol. 2010;29(2):74-77.
76. Cleveland NJ, Yaron M, Ginde AA. The effect of removal of point-of-care fecal occult blood testing on performance of digital rectal examinations in the emergency department. Ann Emerg Med. 2010;56(2):135-141.
77. Siegel AJ, d'Hemecourt P, Adner MM, et al. Exertional dysnatremia in collapsed marathon runners: a critical role for point-of-care testing to guide appropriate therapy. Am J Clin Pathol. 2009;132(3):336-340.
78. Louie RF, Kitano T, Brock TK, et al. Point-of-care testing for pandemic influenza and biothreats. Disaster Med Public Health Prep. 2009;3(Suppl 2):S193-S202.
79. Cervinski MA, Gronowski AM. Reproductive-endocrine point-of-care testing: current status and limitations. Clin Chem Lab Med. 2010;48(7):935-942.
80. Sanford KW, McPherson RA. Fecal occult blood testing. Clin Lab Med. 2009;29(3):523-541.
81. Saenger AK, Christenson RH. Stroke biomarkers: progress and challenges for diagnosis, prognosis, differentiation, and treatment. Clin Chem. 2010;56(1):21-33.